Diametric Capital’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $686K | Buy |
77,523
+18,590
| +32% | +$165K | 0.37% | 78 |
|
|
2025
Q1 | $461K | Buy |
58,933
+31,637
| +116% | +$248K | 0.55% | 55 |
|
|
2024
Q4 | $287K | Sell |
27,296
-4,893
| -15% | -$51.4K | 0.19% | 166 |
|
|
2024
Q3 | $422K | Buy |
32,189
+11,334
| +54% | +$149K | 0.21% | 153 |
|
|
2024
Q2 | $293K | Buy |
+20,855
| New | +$293K | 0.16% | 182 |
|
|
2024
Q1 | – | Sell |
-35,739
| Closed | -$505K | – | 338 |
|
|
2023
Q4 | $505K | Buy |
+35,739
| New | +$505K | 0.31% | 98 |
|